Physician profile
Melissa N Loja
NPI 1578826749
$271,565.00
in general payments reported to CMS, 2019-2025
33 companies · $145K in 2025
The $145K reported for 2025 was more than what 99% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,267 · 2020: $4,308 · 2021: $5,418 · 2022: $15K · 2023: $56K · 2024: $42K · 2025: $145K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $146K · Travel and Lodging: $79K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Food and Beverage: $5,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $146,425.00 |
| Travel and Lodging | $78,840.24 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,700.00 |
| Food and Beverage | $5,437.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $258,351.41 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $5,037.52 | 2023-2025 | Amplatzer Amulet, Supera, Esprit |
| Medtronic, INC. | $2,732.50 | 2021-2025 | Endurant Iis, Valiant Captivia, Swiftset |
| Bard Peripheral Vascular, INC. | $1,346.36 | 2020-2023 | Venovo |
| Medtronic Vascular, INC. | $1,035.16 | 2019 | |
| Boston Scientific Corporation | $583.73 | 2022-2025 | Eluvia, Ranger, Jetstream Sc |
| Reflow Medical INC | $517.02 | 2024-2025 | |
| W. L. Gore & Associates, INC. | $317.55 | 2023-2025 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Cook Medical LLC | $206.85 | 2022-2025 | Zenith Spiral-Z |
| Janssen Pharmaceuticals, INC | $179.59 | 2019-2021 | |
| Philips North America LLC | $147.06 | 2019-2025 | (5044) Mcot, (9281) Turbo Elite, (5091) Amb Mon & Diag Und |
| Inari Medical, INC. | $144.95 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Biotronik INC. | $144.52 | 2023 | Passeo-18 |
| Amgen INC. | $132.96 | 2022-2023 | Repatha |
| Biotissue Holdings INC. | $127.24 | 2023-2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $92.28 | 2025 | Artix Mt, Flowtriever |
| Viz.Ai, INC. | $86.50 | 2022 | |
| Kiniksa Pharmaceuticals, Ltd. | $45.69 | 2021-2022 | |
| Terumo Medical Corporation | $43.40 | 2019-2024 | Azur Cx Detachable |
| Cardiovascular Systems INC. | $41.20 | 2022 | |
| Ethicon US, LLC | $25.00 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $24.93 | 2023 | Uptravi, Opsumit |
| Derma Sciences, INC. | $24.48 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.30 | 2023 | Eliquis |
| Venclose INC. | $23.14 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.25 | 2024 | |
| Mallinckrodt Enterprises LLC | $19.00 | 2019 | |
| Astellas Pharma US INC | $18.16 | 2021 | |
| Penumbra, INC. | $17.06 | 2019 | |
| Pfizer INC. | $16.37 | 2019 | |
| Esperion Therapeutics, INC. | $15.37 | 2021 | |
| Convatec INC. | $13.23 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $12.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Loja listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.